- Home
- BLDR vs COGT Comparison
BLDR vs COGT Comparison
Compare BLDR & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLDR | COGT |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 6.6B |
| IPO Year | 2005 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BLDR | COGT |
|---|---|---|
| Price | $78.90 | $38.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 15 |
| Target Price | ★ $121.76 | $36.21 |
| AVG Volume (30 Days) | 2.2M | ★ 3.0M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $15,190,638,000.00 | $7,871,000.00 |
| Revenue This Year | $0.71 | N/A |
| Revenue Next Year | $4.52 | $1,733.58 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $65.10 | $10.38 |
| 52 Week High | $151.03 | $43.73 |
Technical Indicators
Market Signals| Indicator | BLDR | COGT |
|---|---|---|
| Relative Strength Index (RSI) | 49.92 | 58.02 |
| Support Level | $74.21 | $37.54 |
| Resistance Level | $79.82 | $40.67 |
| Average True Range (ATR) | 3.60 | 1.59 |
| MACD | -0.80 | -0.11 |
| Stochastic Oscillator | 32.18 | 46.02 |
Price Performance
Historical ComparisonAbout BLDR Builders FirstSource Inc.
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.